Amplyx Pharmaceuticals, today announced that preclinical data for fosmanogepix (APX001) will be presented at the upcoming scientific conferences IDWeek 2019 in Washington D.C. from October 2-6, 2019, and the 9th Congress on Trends in Medical Mycology Meeting in Nice, France from October 11-14, 2019.
September 24, 2019
· 4 min read